TERI FRENCH-MIRTSCHINK: Open Payments
NPI 1801855671 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$972 in 49 payments from 11 companies in 2025. Trend: 2023 $1,269 · 2024 $1,441 · 2025 $972
Food & beverage: $972
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $205 |
| Merck Sharp & Dohme LLC | 7 | $126 |
| E.R. Squibb & Sons, L.L.C. | 5 | $122 |
| PFIZER INC. | 4 | $90 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $88 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $72 |
| Amgen Inc. | 4 | $70 |
| Esperion Therapeutics, Inc. | 4 | $65 |
| Novo Nordisk Inc | 3 | $57 |
| Actelion Pharmaceuticals US, Inc. | 2 | $45 |
Products named: LEQVIO, VERQUVO, Kerendia, ELIQUIS, CAMZYOS, JARDIANCE, REPATHA, NEXLETOL.
Industry payments across GA — which companies pay providers there.
